|
|
|
Insider
Information: |
Luo Mary Z. |
Relationship: |
COO,Chief Scientist & ... |
City: |
Rancho Cucamonga |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
2,433,554 |
|
Indirect Shares
|
8,057,435 |
|
|
Direct
Value |
$102,574,301 |
|
|
Indirect Value
|
$339,620,885 |
|
|
Total
Shares |
10,490,989 |
|
|
Total
Value |
$442,195,186 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amphastar Pharmaceuticals, Inc. |
AMPH |
COO,Chief Scientist & ... |
2024-03-17 |
2,433,554 |
2024-03-17 |
8,057,435 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2023-03-17 |
4 |
D |
$36.29 |
$255,917 |
I/I |
(7,052) |
1,455,602 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-17 |
4 |
D |
$20.23 |
$282,026 |
I/I |
(13,941) |
1,399,022 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Science Officer |
|
2015-12-03 |
4 |
AS |
$15.42 |
$286,461 |
I/I |
(18,583) |
7,593,011 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist Chairman |
|
2017-03-26 |
4 |
D |
$13.76 |
$299,954 |
D/D |
(21,799) |
1,199,982 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2024-03-17 |
4 |
D |
$43.05 |
$303,589 |
I/I |
(7,052) |
1,229,756 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2016-03-27 |
4 |
D |
$11.96 |
$309,238 |
D/D |
(25,856) |
1,088,335 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Science Officer |
|
2015-12-01 |
4 |
AS |
$15.49 |
$309,780 |
I/I |
(20,000) |
7,611,594 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Sci. and Chairman |
|
2023-03-15 |
4 |
D |
$36.84 |
$310,709 |
D/D |
(8,434) |
2,177,092 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
|
2015-12-10 |
4 |
AS |
$14.32 |
$313,884 |
I/I |
(21,915) |
7,476,660 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2017-03-17 |
4 |
D |
$13.75 |
$317,735 |
D/D |
(23,108) |
1,221,781 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-03-27 |
4 |
D |
$15.43 |
$322,132 |
D/D |
(20,877) |
911,636 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2024-03-06 |
4 |
D |
$46.31 |
$325,606 |
D/D |
(7,031) |
2,135,997 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2020-03-16 |
4 |
D |
$13.03 |
$337,125 |
D/D |
(25,873) |
2,094,264 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
|
2015-12-08 |
4 |
AS |
$14.50 |
$353,118 |
I/I |
(24,359) |
7,524,894 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
|
2022-03-16 |
4 |
D |
$34.22 |
$356,778 |
I/I |
(10,426) |
1,505,571 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
|
2022-05-20 |
4 |
AS |
$34.21 |
$364,365 |
D/D |
(10,650) |
2,104,143 |
0 |
% |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-09 |
4 |
OE |
$12.97 |
$367,362 |
D/D |
28,324 |
947,837 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-09 |
4 |
OE |
$12.97 |
$368,776 |
I/I |
28,433 |
699,324 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2023-03-16 |
4 |
D |
$37.60 |
$375,925 |
I/I |
(9,998) |
1,462,654 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
|
2015-12-09 |
4 |
AS |
$14.29 |
$376,133 |
I/I |
(26,319) |
7,498,575 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2018-03-16 |
4 |
D |
$19.91 |
$385,458 |
D/D |
(19,360) |
2,091,834 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2020-03-15 |
4 |
D |
$14.19 |
$385,670 |
D/D |
(27,179) |
2,120,137 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2018-03-26 |
4 |
D |
$18.61 |
$385,748 |
D/D |
(20,728) |
2,040,619 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-08 |
4 |
OE |
$12.97 |
$389,956 |
D/D |
30,066 |
946,533 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-08 |
4 |
OE |
$12.97 |
$391,071 |
I/I |
30,152 |
697,991 |
0 |
- |
|
170 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|